Patent classifications
A61N5/1016
METHODS AND DEVICES FOR DISPLACING TISSUES DURING BRACHYTHERAPY
Tubular constructs attached to a brachytherapy device allowing for the selected displacement of surrounding tissue at a site of radiation application. Tubular constructs have an inflatable balloon portion and an attached non-inflating stem tube. Balloon portions are affixed to the brachytherapy device and inflated with the stem tube to displace tissue away from an area.
Brachytherapy applicator device for insertion in a body cavity
The invention relates to a brachytherapy applicator device for insertion in a body cavity. The applicator device comprises an applicator shaped for insertion in the body cavity; the applicator comprising connectable segments; at least one connectable part having a form following wall surface shaped to follow the body cavity, the wall surface having a multichannel groove structure, so as to guide a plurality of catheters along the grooves in the groove structure along the wall surface.
Systems and methods for treating cancer using brachytherapy
Systems and methods are provided for treating cervical and/or uterine cancers in brachytherapy with an intracavitary brachytherapy applicator. The system comprises a tandem adapted for insertion into a cervix of a patient. An ovoid assembly comprises first and second inflatable ovoids and an ovoid support mechanism. The first and second inflatable ovoids are adapted for insertion within fornices of a patient. First and second retractors are adapted to be coupled to the ovoid assembly. The first retractor is adapted to be positioned to retract the bladder of a patient during treatment. The second retractor is adapted to be positioned to retract the rectum of a patient during treatment. The tandem and the first and second inflatable ovoids are adapted to be coupled to a radioactive source to deliver an implant radiation dose suitable for cancer treatment at a cancerous cervical treatment site in a patient.
COMPOSITION FOR CANCER CELL SENSITIZATION CONTAINING AS ACTIVE INGREDIENT SUBSTANCE INHIBITING EXPRESSION OF ONCOGENE OF HPV VIRUS
The present invention relates to a composition for cancer cell sensitization containing as an active ingredient a substance inhibiting the expression of an oncogene of a HPV virus, and more specifically, to a composition for radiosensitization which is used for the treatment of cancer induced by HPV infection and contains as an active ingredient oligonucleotide having any one nucleic acid sequence selected from the group consisting of sequence numbers 1 to 10. The oligonucleotide of the present invention inhibits the expressions of E6 and E7 which are HPV virus oncoproteins, thereby inhibiting the proliferation of tumor cells, and enhances the sensitivity of tumor cells to radiation, thereby exhibiting an excellent effect as a sensitizer that can maximize the cell death effect.
Multi-segmented inflatable brachytherapy devices, systems, and methods of using the same
Provided are multi-segmented inflatable brachytherapy devices. Also provided are systems and methods including multi-segmented inflatable brachytherapy devices.
Systems and methods for treating cancer using brachytherapy
Systems and methods are provided for treating cervical and/or uterine cancers in brachytherapy with an intracavitary brachytherapy applicator. The system comprises a tandem adapted for insertion into a cervix of a patient. An ovoid assembly comprises first and second inflatable ovoids and an ovoid support mechanism. The first and second inflatable ovoids are adapted for insertion within fornices of a patient. First and second retractors are adapted to be coupled to the ovoid assembly. The first retractor is adapted to be positioned to retract the bladder of a patient during treatment. The second retractor is adapted to be positioned to retract the rectum of a patient during treatment. The tandem and the first and second inflatable ovoids are adapted to be coupled to a radioactive source to deliver an implant radiation dose suitable for cancer treatment at a cancerous cervical treatment site in a patient.
Brachytherapy Applicator
A brachytherapy cervix applicator is disclosed comprising a cervix piece capable of reaching the cervix for radiation treatment and a uterus treatment piece comprising a moderately bendable and movable tube to aid insertion to uterus and an inflatable balloon in the uterus treatment piece to provide extra immobilization to the applicator inside the vaginal cavity. Optionally there is at least one radiation side-delivery channel located outside of the balloons.
TANDEM WITH CAMERA SYSTEM AND METHOD
A tandem applicator assembly for brachytherapy that includes a tandem and a camera system. The tandem has a tubular main body with a trail end and a lead end. A transparent cap is affixed to the lead end. The camera system is removably received by the tandem through the trail end of the tubular main body. The camera system is disposed inside of the transparent cap. The camera system includes at least one digital camera configured to acquire color images from a patient through the transparent cap. The tandem applicator assembly may be used with a treatment planning system and method for customizing a treatment plan for a patient undergoing brachytherapy.
BRACHYTHERAPY APPLICATORS HAVING ULTRASOUND ELEMENTS
A brachytherapy system includes a brachytherapy applicator. The brachytherapy applicator includes an applicator tube and a radiation source configured to deliver radiation to a tumor. At least a portion of the applicator tube is configured to conform to at least a portion of a patient's anatomy. At least one ultrasound element or probe is coupled to or embedded with the applicator tube.
Brachytherapy applicator device and method of use thereof
An applicator device is provided including a connecting unit. The connecting unit includes a first connector coupled to a first colpostat and a second connector coupled to a second colpostat. The first connector includes a first contact portion and a body portion, the first contact portion being immovably fixed to the body portion. The second connector includes a second contact portion and a third contact portion, the second contact portion being configured to contact and pivotally engage the first contact portion. The first connector further includes a fourth contact portion configured to contact the third contact portion. The second contact portion and the third contact portion are disposed between the first contact portion and the fourth contact portion, and the first contact portion are disposed in closer proximity to a point of delivery of a radiation source than the second, third, or fourth contact portions.